ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.595
-0.045 (-2.74%)
Apr 29, 2026, 11:55 AM EDT - Market open
ALX Oncology Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 215 | 61 | 88 | 742 | 459 | 870 | |
| Market Cap Growth | 720.48% | -30.44% | -88.13% | 61.50% | -47.23% | -74.66% | |
| Enterprise Value | 191 | 16 | -43 | 567 | 181 | 488 | |
| Last Close Price | 1.64 | 1.13 | 1.67 | 14.89 | 11.27 | 21.49 | |
| PB Ratio | 3.43 | 2.36 | 0.78 | 3.91 | 1.74 | 2.40 | |
| P/TBV Ratio | 8.49 | 2.36 | 0.78 | 3.91 | 1.74 | 2.40 | |
| Debt / Equity Ratio | 0.57 | 0.57 | 0.09 | 0.05 | 0.04 | 0.00 | |
| Net Debt / Equity Ratio | -1.15 | -1.15 | -1.04 | -0.91 | -0.97 | -1.00 | |
| Net Debt / EBITDA Ratio | 0.30 | 0.30 | 0.83 | 1.02 | 2.02 | 4.35 | |
| Net Debt / FCF Ratio | 0.36 | 0.36 | 0.96 | 1.32 | 2.83 | 5.28 | |
| Quick Ratio | 1.84 | 1.84 | 6.95 | 5.10 | 9.40 | 23.78 | |
| Current Ratio | 2.07 | 2.07 | 7.26 | 5.24 | 9.57 | 24.00 | |
| Return on Equity (ROE) | -145.70% | -145.70% | -88.91% | -70.97% | -39.42% | -21.05% | |
| Return on Assets (ROA) | -60.95% | -60.95% | -45.62% | -38.77% | -23.20% | -12.80% | |
| Return on Capital Employed (ROCE) | -292.40% | -292.40% | -110.20% | -82.40% | -45.80% | -22.90% | |
| Earnings Yield | -46.08% | -165.99% | -153.10% | -21.68% | -26.88% | -9.59% | |
| FCF Yield | -38.22% | -137.68% | -138.92% | -17.75% | -19.74% | -7.90% | |
| Buyback Yield / Dilution | -2.84% | -2.84% | -21.37% | -5.62% | -0.97% | -118.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.